ArticleFrontiers in neurology2025
Reduced global BOLD-CSF coupling in chronic kidney disease-related cognitive impairment: a resting-state functional MRI study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Chronic kidney disease and cognitive decline: choroid plexus remodeling, glymphatic dysfunction, and alzheimer biomarker interpretation.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Review
- Multiplex functional connectome graph transformer for cognitive vulnerability in dialysis-treated chronic kidney disease.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cognitive impairment is a common complication of chronic kidney disease (CKD), but its underlying mechanisms are not fully understood. This study aims to investigate the glymphatic system function in CKD patients with and without cognitive impairment (CI) by analyzing the coupling between the global blood oxygen level-dependent (gBOLD) signal and the cerebrospinal fluid (CSF) signal using resting-state functional magnetic resonance imaging (rs-fMRI). Methods: Twenty-nine patients with CKD were enrolled (19 with CI and 10 without), along with 22 healthy controls (HCs). All patients underwent high-resolution structural MRI and rs-fMRI scans. The gBOLD-CSF coupling was quantified by calculating the maximum negative correlation within a predefined time-lag range between the gBOLD signal and the fourth ventricular CSF signal. The gBOLD-CSF coupling was compared between the CKD and HC groups using analysis of covariance (ANCOVA), adjusting for age, sex, education, and mean framewise displacement (FD). The difference between patients with CKD with and without CI was assessed using ANCOVA, after adjusting for age, sex, education, hypertension, diabetes, and mean FD. Partial correlation analysis was performed to explore the associations between gBOLD-CSF coupling and clinical indicators, such as estimated glomerular filtration rate (eGFR), Montreal Cognitive Assessment (MoCA) scores, and other laboratory data. Results: After adjusting for covariates, gBOLD-CSF coupling was significantly lower in the CKD group than in the HC group ( Conclusion: Patients with CKD exhibit impaired glymphatic system function, manifested as reduced gBOLD-CSF coupling, which is associated with the severity of CI. These findings support the hypothesis that impaired glymphatic clearance may contribute to cognitive decline in CKD via the kidney-brain axis. Larger longitudinal studies are needed to validate its clinical significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.